We are investigating whether a new oral medication combined with another drug can help patients with advanced solid tumors. This study aims to explore the effectiveness of this treatment approach.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic Triple Negative Breast Cancer (TNBC) is a type of breast cancer that lacks estrogen, progesterone, and HER2 receptors, making it more challenging to treat. It can spread to other parts of the body, leading to advanced disease.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.